Thanh Cheng, MD
Hope Biosciences Stem Cell Research Foundation
5
5
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Avindra Nath, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Shared therapeutic areas:
Xiaolong Qi, MD
LanZhou University
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Toshimitsu Tokimoto
Astrazeneca KK
Shared therapeutic areas:
Wenhong Zhang, MD
Huashan Hospital
Shared therapeutic areas:
Mitchell S Cairo, MD
New York Medical College
Shared therapeutic areas:
Mohamed mamdouh Elsayed, MD
Lecturer
Shared therapeutic areas:
Marie Carmen Valenza, phD
Universidad de Granada
Shared therapeutic areas:
Melissa Stockwell, MD MPH
Columbia University
Shared therapeutic areas:
Matthew J Memoli, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.
A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19
Individual Patient Expanded Access IND to Treat Polyneuropathy
Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome
Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)
All 5 trials loaded